Global Glucoma Surgical Devices Market Research Report 2019 (Includes Business Impact of COVID-19)

                                          
"The ongoing Coronavirus (COVID-19) pandemic is re-shaping everything from global economies to product categories, pricing, and stock availability to the consumer behavior. The final report is updated to address the impact of COVID-19 on the Glucoma Surgical Devices market.

Trusted Business Insights is tracking mining/oil and gas, transportation, employment services, travel arrangements, and the leisure and hospitality sector closely as they are likely to be the hardest-hit sectors. Utilities, local pharma, diagnostics, consumer goods and durables, agro chem and fertilizers, and telecommunications are the sectors that will be weathering the COVID-19 storm and most likely come out relatively unscathed. Interdependencies of sectors are factored in our research report on the Glucoma Surgical Devices market."
Glaucoma is an ocular disease which affects the optic nerve of the iris and progression of the same results in vision loss and blindness. According to the World Health Organization (WHO), glaucoma is the most cause of blindness across the world. Currently, there are no existing treatments for glaucoma; however, some commercially available therapies focus on reducing the intraocular pressure, which is responsible for the development and progression of the disease. The treatment for glaucoma starts with topical eye drops, which is an alternative used to delay surgery.
Growing prevalence of diabetes, eye disorders such as macular degeneration, aging population and growing government initiatives are observed to be the drivers of the global glaucoma surgical devices market. Increasing pool of geriatric population has been a prominent market driver, while corresponding to early disease diagnosis and treatment. As the global aging population and diabetic patient pool is perpetually increasing, it is anticipated that the future of glaucoma surgical devices market is ensured steady growth.

The global Glucoma Surgical Devices market is valued at 410 million US$ in 2018 is expected to reach 2990 million US$ by the end of 2025, growing at a CAGR of 28.3% during 2019-2025.
This report focuses on Glucoma Surgical Devices volume and value at global level, regional level and company level. From a global perspective, this report represents overall Glucoma Surgical Devices market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

The following manufacturers are covered:
    Abbott Laboratories
    AqueSys
    Carl Zeiss Meditec
    Ellex Medical Lasers Limited
    Endo Optiks
    Glaukos
    InnFocus
    Iridex Corporation
    Lumenis
    Neomedix

Segment by Regions
    North America
    Europe
    China
    Japan

Segment by Type
    Glaucoma Drainage Devices
    Glaucoma Laser Devices
    Implants & Stents

Segment by Application
    Eye Hospitals
    Ophthalmology Clinics
    Outpatient Surgical Centers